AIM
GSK icon

AXA Investment Managers’s GSK GSK Stock Holding History

AXA Investment Managers’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$250K Buy
+5,787
New +$226K ﹤0.01% 1070

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AXA Investment Managers's GSK Position: Q3 2025 in Review

AXA Investment Managers opened a new position in GSK (GSK) in Q3 2025: 5,787 shares worth $250K. The stake represents ﹤0.01% of the portfolio and ranks #1070 among its holdings.

895 funds tracked by Wall St. Rank hold GSK as of Q3 2025.

  • AXA Investment Managers held 5,787 shares of GSK worth $250K as of Q3 2025.
  • GSK was a new AXA Investment Managers position in Q3 2025.
  • GSK made up ﹤0.01% of AXA Investment Managers's portfolio in Q3 2025, its #1070 holding.
  • 895 funds tracked by Wall St. Rank held GSK as of Q3 2025.

Based on AXA Investment Managers's 13F filing for Q3 2025, filed 14 Nov 2025.